Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
about
Molecular biology of lung cancerMolecular biology of lung cancer: clinical implicationsMolecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancersImpact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trialsOptimizing the management of advanced non-small-cell lung cancer: a personal viewNon-small cell lung cancer: current treatment and future advancesSomatic DNA mutation analysis in targeted therapy of solid tumoursMolecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-CancerMolecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularK-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive ValueEtiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionPreclinical Murine Models for Lung Cancer: Clinical Trial ApplicationsPromising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLCPooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.CIViC databaseMolecular pathology of non-small cell lung cancer: a practical guide.Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model.Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALKRAS oncogenes: weaving a tumorigenic webGenomic aberrations in lung adenocarcinoma in never smokersStatistical methods for studying disease subtype heterogeneityE-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPasesNovel insights into the molecular origins and treatment of lung cancerCharacteristics of lung cancers harboring NRAS mutationsLung cancer in womenProportion and clinical features of never-smokers with non-small cell lung cancerFamilial risk for lung cancerRationale for RAS mutation-tailored therapies.A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.Reconstructing targetable pathways in lung cancer by integrating diverse omics dataEast meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer.Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinomaDiagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.Management of patients with advanced non-small cell lung cancer: role of gefitinibMortality in the randomized, controlled lung intergroup trial of isotretinoin
P2860
Q24606677-70AC1006-B06C-40FA-A473-4AE0FC524CECQ24610335-02604E1B-7693-4F85-8A8B-E059FC914750Q24611043-48A6D43F-B888-4C6B-8F47-4DC4AEBAF861Q24625201-CD11D8EB-C73B-40AD-A77C-EB354C165060Q24656144-B1C81683-F0C5-41A8-B09B-04F9FE38AFE9Q26740333-003B7D42-3532-4D7E-BE80-60DA01BF4C8CQ26770324-4B0F7899-E177-458F-92A3-F25E3D23F3A8Q26771116-70CBFC8F-7E26-46FB-916F-1E854A9CE932Q26828860-B70840D7-2487-49B2-AC9D-8507B858C62DQ26829425-9EBB892E-09CA-4B21-8C10-162FC0084D7AQ26852716-AA78A55A-34F9-46C7-AD19-E3F80158DCE3Q26863474-7F2E474F-B94C-4900-BDB5-07022CE6280CQ27025970-474D8498-53A3-48CD-AB59-CE3F5DE432DEQ27313799-A731BD6F-06F2-48B3-A983-434652214C35Q27612411-23FAFD64-E7E3-43BF-8246-A75B4AC7ECA5Q27690919-1372D8B2-A567-490B-8CA9-52768AD4D106Q27853346-F5C9156B-03B1-4AC7-89CD-54AD9708E331Q28083446-40DFAC66-7A03-4FFB-8DE3-1C0D67C4FBE2Q28250360-36A08353-4250-408F-B352-DC9ABE3F2EE5Q28385032-54DE12E0-E320-4BAC-9C1B-F3CCAA6920C6Q28385063-C1E64208-EADE-4E1C-B2D0-9729EA9FF1B9Q28385103-F45999C4-79EC-4D25-88A8-6E7AD972B7A0Q28386773-E9FEBAA1-E113-440E-9EA6-F43E3957E27EQ28706226-22D9498F-9B01-42D7-8FBF-77649A8EF5BAQ29248783-09168725-5A6B-4D57-99D7-B1B612D53AA2Q29248786-4A0882B4-A231-4861-BD74-BB1BAE7DB464Q29249088-DE2ACE75-E3E5-40CA-92CA-B34466955BDDQ30244673-FE78F154-9163-4C96-A4BD-14EA4DAAD737Q30603151-09C3D236-00AA-422D-A757-A4690C57EE48Q30679547-3C0259FF-8037-40B0-8B06-DBB9C46539B3Q33579631-F6F97659-93E5-41FB-905A-06E562B951A5Q33607511-D12F368F-5E22-4CF1-8BF0-C87F262709BAQ33682941-2B472A61-1B69-48CA-BC77-23D8E3607351Q33690682-8D9BF1D7-81A2-4D3D-80C3-993F29A23230Q33787405-78971A52-83E0-4165-863F-845269E9732DQ33829668-FD379173-FB40-4421-AF1D-568D3CBC6F25Q33857897-AD57C303-9864-4A3A-A8E4-78456F674ECEQ33878516-3DCC8912-E809-4292-A543-5F3EE0CEA053Q33892597-38359B5C-6A84-4B20-849C-EC398E18E49DQ33895618-BDDA5DAD-8DBD-4F63-80E7-20C880F372BA
P2860
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@ast
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@en
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@nl
type
label
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@ast
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@en
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@nl
altLabel
Frequency and Distinctive Spec ...... okers with Lung Adenocarcinoma
@en
prefLabel
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@ast
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@en
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@nl
P2093
P2860
P3181
P1476
Frequency and distinctive spec ...... kers with lung adenocarcinoma.
@en
P2093
Daniel Rosenbaum
Dhananjay A Chitale
Elyn R Riedel
Gregory J Riely
Jenifer Marks
Khedoudja Nafa
Mark G Kris
Vincent A Miller
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-08-0646
P407
P577
2008-09-15T00:00:00Z